SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-13-004774
Filing Date
2013-12-10
Accepted
2013-12-10 16:27:02
Documents
10
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pergrine_10q-103113.htm 10-Q 566372
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER peregrine_ex3101.htm EX-31.1 7730
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER peregrine_ex3102.htm EX-31.2 7591
4 CERTIFICATION peregrine_ex32.htm EX-32 5998
  Complete submission text file 0001019687-13-004774.txt   3270687

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20131031.xml EX-101.INS 433862
6 XBRL SCHEMA FILE pphm-20131031.xsd EX-101.SCH 26000
7 XBRL CALCULATION FILE pphm-20131031_cal.xml EX-101.CAL 46607
8 XBRL DEFINITION FILE pphm-20131031_def.xml EX-101.DEF 61506
9 XBRL LABEL FILE pphm-20131031_lab.xml EX-101.LAB 210793
10 XBRL PRESENTATION FILE pphm-20131031_pre.xml EX-101.PRE 155806
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 131268690
SIC: 2834 Pharmaceutical Preparations